Comparison of GLP-1 Analogues versus Sitagliptin in the Management of Type 2 Diabetes: Systematic Review and Meta-Analysis of Head-to-Head Studies

BACKGROUND: Incretin–based therapies which include glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors are recommended by several practice guidelines as second-line agents for add-on therapy to metformin in patients with type 2 diabetes (T2DM) who do not a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tiansheng, Gou, Zhuoyue, Wang, Fei, Ma, Manling, Zhai, Suo-di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121242/
https://www.ncbi.nlm.nih.gov/pubmed/25089625
http://dx.doi.org/10.1371/journal.pone.0103798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121242/
https://www.ncbi.nlm.nih.gov/pubmed/25089625
http://dx.doi.org/10.1371/journal.pone.0103798

Ejemplares similares